Bionano Genomics
BNGO
BNGO
140 hedge funds and large institutions have $146M invested in Bionano Genomics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 44 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
23% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 44
Holders
140
Holding in Top 10
–
Calls
$6.56M
Puts
$2.96M
Top Buyers
| 1 | +$1.95M | |
| 2 | +$1.09M | |
| 3 | +$573K | |
| 4 |
D.E. Shaw & Co
New York
|
+$490K |
| 5 |
Goldman Sachs
New York
|
+$284K |
Top Sellers
| 1 | -$4.11M | |
| 2 | -$1.7M | |
| 3 | -$1.47M | |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$1.18M |
| 5 |
Two Sigma Investments
New York
|
-$592K |